Hemosurveillance and optimal use of blood components in hospitals
Keywords:
DeCS, Blood supply, Transfusion reaction, Blood donors, statistics & numerical data.Abstract
Introduction: the development of an accurate hemosurveillance report is very important along with an analysis of adverse reactions in the transfusion chain regarding the rational and scientific use of blood transfusion.Objective: to evaluate the reports of adverse reactions in the transfusion chain and the use of blood components.Methods: a descriptive cross-sectional study was conducted, the data obtained from the records of donations, transfusions and adverse reactions between the years 2013 and 2014 at Abel Santamaria Cuadrado General Teaching Hospital along with the results of the initial screening for infectious markers were analyzed. Transfusion reactions were assessed according to their severity and accountability.Results: 9777 blood donations were processed, available 8919 (91.2%), after the screening of infectious markers 325 (3.3%); in relation to the adverse reactions from the donor, the hematoma was the most frequent; 11.226 patients were transfused, 174 less than in 2013, with 13.759 units of blood components managed. There were 84 suspected (80 immediate and 4 later). Transfusion adverse reactions, the first reported was the acute lung injury associated with transfusion (3), and 9 other late associated events. The maximum age of notification was 98 years, depending on the severity, where these patients died as a consequence of an anaphylactic type reaction. Conclusions: Hemosurveillance starts since the donation fewer patients were transfused and smaller amount of units used in 2014, the hospital transfusion committee analyzed the stability of benefits and risks of the blood transfusions in the hospital to optimize their use.
Downloads
References
1. Murphy MF, Walters JH, Wood EM, Yazer MH. Estrategias para realizar transfusiones seguras y apropiadas. BMJ [Internet]. 2013 [citado 08 Abr 2016]; 347:4303. Disponible en: http://www.intramed.net/contenidover.asp?contenidoID=81024
2. Delgado MB. Transfusión sanguínea. Uso racional. Rev Colomb Anestesiol [Internet]. 2012 Nov-Dic [citado 08 Abr 2016]; 40(4): 247-8. Disponible en: http://www.sciencedirect.com/science/article/pii/S0120334712000536
3. Faber JC. Haemovigilance around the world. Vox Sang [Internet]. 2002 Aug [citado 08 Abr 2016]; 83(Supll-S1): 71-6. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1423-0410.2002.tb05271.x/full
4. Silva Ballester HM, Bencomo Hernández A, Ballester Santovenia JM. Desarrollo de un sistema de hemovigilancia en la provincia de Matanzas. Reporte Técnico de de Vigilancia [Internet]. 2006 May-Jun [citado 08 Abr 2016]; 11(3):. Disponible en: http://www./cu/galerias/pdf/sitios /vigilancia/silva 32006.pdf
5. Silva Ballester HM. Programa de hemovigilancia para los servicios de salud de la provincia de Matanzas [Internet]. Villa Clara, Cuba: Universidad de Ciencias Médicas de Villa Clara; 2012 [citado 08 Abr 2016]. Disponible en: http://tesis.repo.sld.cu/436/
6. Gobierno de España. Secretaria General de Sanidad. Dirección General de Salud Pública y Sanidad Exterior. Informe de Hemovigilancia 2012 [Internet]. España: Subdirección General de Promoción de la Salud y Epidemiología; 2012 [citado 21 Nov 2015]. Disponible en: http://www.msssi.gob.es/profesionales/saludPublica/medicinaTransfusional/hemovigilancia/docs/Informe2012.pdf
7. Sánchez Frenes P, Sánchez Bouza MJ, Hernándes Malpica S, Fariñas Reinoso AT. Vigilancia activa de enfermedades infecciosas en donantes de sangre. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2013 Ene-Mar [citado 08 Abr 2016]; 29(1): 82-9. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892013000100009&script=sci_arttext
8. Ballester Santovenia JM. Reacciones adversas no infecciosas de la transfusión de sangre y componentes. En: ABC de la medicina transfusional. Guías clínicas. Cuba 2006. La Habana: Ministerio de Salud Pública; 2006. p. 37-40.
9. Gutiérrez Camacho PJ. Reacciones transfusionales en el Hospital General de México. Rev Med Hosp Gen Mex [Internet]. 2007 [citado 08 Abr 2016]; 70(2): 67-72. Disponible en: http://www.medigraphic.com/pdfs/h-gral/hg-2007/hg072c.pdf
10. Kumar P, Thapliyal R, Coshic P, Chatterjee K. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J Transfus Sci [Internet]. 2013 Jul [citado 08 Abr 2016];7(2):109-15. Disponible en: http://www.pubfacts.com/detail/24014939/Retrospective-evaluation-of-adverse-transfusion-reactions-following-blood-product-transfusion-from-a
11. Román Torres R, Fernández Delgado ND. Trali, una amenaza enmascarada: definición, aspectos epidemiológicos y clínicos. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2015 Mar [citado 08 Abr 2016]; 31(1): 4-19. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892015000100002&lng=es
12. Mendoza LL, Cruz Rodríguez L, Oropeza Uribe Y, Medina Olvera C, Mejía Domínguez AM. Diseño y validación de un instrumento para el registro de reacciones adversas a la donación de sangre y sus componentes. Revista Mexicana Enfermería Cardiológica [Internet]. 2013 May-Ago [citado 08 Abr 2016]; 21(2): 50-6. Disponible en: http://www.medigraphic.com/pdfs/enfe/en-2013/en132b.pdf
13. Silva Ballester HM, Bencomo Hernández AA, López Fernández R, Benet Rodríguez M, Ballester Santovenia JM. La hemovigilancia de las reacciones adversas a la donación de sangre. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2013 Abr-Jun [citado 08 Abr 2016]; 29(2): 154-62. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892013000200006
14. Sánchez Frenes P, Fariñas Reinoso AT, Rojo Pérez N, Hernández Malpica S. Diseño de un sistema de vigilancia para infecciones transmitidas por transfusión de sangre en Cienfuegos. Rev Cubana Salud Pública [Internet]. 2011 [citado 08 Abr 2016]; 37(2):. Disponible en: http://www.bvs.sld.cu/revistas/spu/vol37_02_11/spu13211.htm.
15. Ballester JM, Alfonso ME, Ballester L, Bencomo AA, Cortina L, Macías C, et al. Procederes de bancos de sangre y servicios de transfusiones. La Habana: Instituto de Hematología e Inmunología, Organización Panamericana de la Salud; 2004.
16. Melians Abreu S, Díaz Noda V, Prieto Hernández J, Esquivel Hernández M. Daño pulmonar agudo asociada a transfusión en el embarazo. Reporte de casos. Revista de Ciencias Médicas de Pinar del Río [Internet]. 2014 [citado 08 Abr 2016]; 18(4): Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/1656
17. Nuñez Mesa CO. La transfusión de sangre y el método clínico. Revista Archivo Médico de Camagüey. [Internet] 2013 [citado 08 Abr 2016]; AMC vol.17 no.6 Camagüey nov.-dic. Disponible en:
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552013000600002
18. Barroso Sepúlveda HE. Diseño de un modelo de gestión para el centro de sangre de Concepción “Dra. Marcela Contreras Arriagada” [Internet]. Chile: Universidad del Bio-Bio Facultad de ingeniería; 2009 [citado 08 Abr 2016]. Disponible en: http://www.uci.ac.cr/Biblioteca/Tesis/PFGMIA106.pdf
19. Martínez Martínez A, Rivero Jiménez RA, Fernández Delgado N. Efectos adversos en la cadena transfusional en el Instituto de Hematología e Inmunología. Rev Cubana Hematol, Inmunol Hemoter [Internet]. 2015 Jul-Sep [citado 08 Abr 2016]; 31(3): 288-300. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892015000300007&script=sci_arttext&tlng=en
20. Martínez Martínez A, Román Torres R, Fernández Delgado N. Es posible la transfusión de plaquetas no isogrupo ABO?. Carta al director. Rev Cubana Hematol, Inmunol Hemoter [Internet]. 2015 Jul-Sep [citado 08 Abr 2016];31(3): 334-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892015000300013
21. Muñiz Díaz E. De la Hemovigilancia al uso óptimo de la sangre. Cataluña, Madrid: Ministerio de Sanidad; 2011.
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
